U.S. Stocks Mostly Lower, Nasdaq Drops Over 50 Points
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 17 2026
0mins
Should l Buy GXAI?
Source: Benzinga
- Market Performance: U.S. stocks traded mostly lower on Tuesday, with the Nasdaq Composite falling over 50 points, and the S&P 500 dropping 0.13% to 6,827.16, indicating a cautious investor sentiment amid market weakness.
- Company Highlights: Medtronic PLC (NYSE:MDT) reported an adjusted EPS of $1.36 for Q3, exceeding market expectations of $1.33, with quarterly sales of $9.017 billion surpassing the $8.905 billion forecast, showcasing the company's strong earnings capability.
- Sector Dynamics: Financial shares gained 0.9%, while materials stocks fell by 2%, reflecting a divergence in market performance as investors may be seeking more defensive investment opportunities amidst volatility.
- Economic Indicators: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, up from 7,750 in the previous period, indicating an improving labor market trend.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GXAI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GXAI
About GXAI
Gaxos.ai Inc. is a technology-based company. The Company is focused on addressing health, longevity, and entertainment, through artificial intelligence (AI) solutions. The Company's offerings include health, wellness and gaming. Its flagship product is its gaming platform called Gaxos (Gaxos Gaming), created to develop, design, acquire, and manage conventional games and to combine these games with unconventional game mechanisms, such as the ability for gamers and developers to utilize artificial intelligence to create and design in-game features, as well as to mint in-game features, such as skins, characters, weapons, gear, levels, and virtual lands, in the form of non-fungible tokens (NFTs) that allows users to have experiences and more control over in-game assets. Its Gaxos Health integrates AI-driven insights with individual biometric data and health goals to create Web and application based personalized wellness strategies for users.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Strategic Investment Expansion: Gaxos.ai announced the acquisition of a 19.99% stake in America First Defense, a U.S. defense technology firm, marking a strategic shift from AI content tools to defense technology, aiming to capitalize on the rapidly growing defense market opportunities despite undisclosed financial terms.
- Focus on Technological Innovation: America First Defense is developing next-generation security platforms, including a detachable counter-drone system and a biomimetic soft robotics platform, addressing the needs of the Department of War and Homeland Security, thereby enhancing Gaxos's competitiveness in the defense tech sector.
- Market Demand Driven: With increasing demand for American-made, scalable defense systems, America First Defense's strategy aligns closely with market trends, potentially providing Gaxos.ai with new revenue streams and business growth opportunities in the defense sector.
- AI Platform Synergy: Gaxos.ai recently finalized an agreement with Byteplus, securing preferred pricing and significant discounts, which will accelerate the rollout of AI features on its Art-Gen platform, further strengthening its market competitiveness as usage grows.
See More
- Missile Supply Chain Opportunity: Mobix Labs has secured a significant production order for components used in the U.S. Navy's Tomahawk missile program, including high-reliability filtering components designed to protect sensitive electronics, reflecting ongoing demand for qualified components and enhancing Mobix's competitiveness in the defense market.
- Spider Silk Technology Breakthrough: Kraig Biocraft Laboratories' recombinant spider silk technology was featured on the cover of National Geographic, showcasing the tensile strength of its genetically enhanced silkworm platform, with plans to deploy approximately one million silkworm eggs in Vietnam, potentially making KBLB the second company to achieve commercial-scale production from a transgenic animal platform.
- Investment in Electronic Warfare: Gaxos.ai has acquired a 19.99% stake in America First Defense, which is developing a drone countermeasure system designed to neutralize hostile UAVs through cyber attacks, reflecting the growing demand for scalable, American-owned counter-autonomy solutions at the intersection of AI and defense innovation.
- Energy Capital Raise: Battalion Oil Corporation has reached an agreement to raise approximately $15 million with a new institutional investor, expecting net proceeds of about $14.1 million, aimed at enhancing financial flexibility amid price volatility in the small-cap energy sector.
See More
- Partnership Enhances AI Capabilities: Gaxos.ai has partnered with Byteplus, the Enterprise Technology Division of ByteDance, which is expected to significantly enhance Gaxos' AI capabilities and accelerate the deployment of AI tools in its flagship platform, Art-Gen, thereby improving its market penetration in the rapidly growing creator economy.
- Preferred Pricing Strategy: Under the agreement, Gaxos will receive preferred pricing and discounts on ByteDance's advanced video generation models, which not only helps to improve Gaxos' gross margins but also accelerates its technology application, further solidifying its competitive edge in the AI space.
- Short-Term Trading Trend Analysis: Gaxos.ai is currently trading 3.9% below its 20-day simple moving average and 8.1% above its 50-day moving average, reflecting a mixed short-term trading trend, with shares decreasing by 23.60% over the past 12 months.
- Technical Indicator Interpretation: The current Relative Strength Index (RSI) stands at 48.78, indicating neutral territory, while the MACD is at -0.0078, below its signal line at 0.0201, suggesting bearish pressure on the stock, and the combination of these indicators reflects the complexity of market momentum.
See More
- Earnings Surprise: Pitney Bowes reported an adjusted EPS of 45 cents for Q4, surpassing the analyst consensus of 38 cents, indicating strong profitability and boosting investor confidence.
- Sales Miss: The quarterly sales of $478 million fell short of the expected $486.68 million, highlighting some market demand challenges that could impact future revenue growth.
- Stock Surge: The company's shares jumped 7.9% to $11.05 in pre-market trading, reflecting optimistic market sentiment regarding its future prospects and potentially attracting more investor interest.
- Positive Guidance: Pitney Bowes issued FY26 adjusted EPS guidance with a midpoint above estimates, further strengthening market confidence in its long-term growth potential.
See More
- Market Performance: U.S. stocks traded mostly lower on Tuesday, with the Nasdaq Composite falling over 50 points, and the S&P 500 dropping 0.13% to 6,827.16, indicating a cautious investor sentiment amid market weakness.
- Company Highlights: Medtronic PLC (NYSE:MDT) reported an adjusted EPS of $1.36 for Q3, exceeding market expectations of $1.33, with quarterly sales of $9.017 billion surpassing the $8.905 billion forecast, showcasing the company's strong earnings capability.
- Sector Dynamics: Financial shares gained 0.9%, while materials stocks fell by 2%, reflecting a divergence in market performance as investors may be seeking more defensive investment opportunities amidst volatility.
- Economic Indicators: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, up from 7,750 in the previous period, indicating an improving labor market trend.
See More
- Production Strategy Shift: Kraig Biocraft Laboratories announced its 2026 production strategy has officially transitioned into execution mode, targeting a monthly output of 10 metric tons of recombinant spider silk cocoons, marking an ambitious scale-up in the advanced materials market.
- Commercialization Progress: This production shift is seen as a pivotal step from planning to production, expected to drive sustainable supply contracts and downstream revenue visibility, thereby enhancing market competitiveness.
- AI Technology Partnership: Gaxos.ai finalized a deal with BytePlus, securing preferred pricing and early access to advanced video generation models, which is anticipated to enhance deployment speed and gross margins for its AI video tools.
- Enterprise Security Expansion: Bond completed a one-year pilot with one of the world's largest employers, and if converted into a broader rollout, it could generate over $10 million in annual revenue, highlighting its growth potential in the corporate security sector.
See More






